Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,251 | 150,672 | -22,906 | -40,079 | -45,903 |
| Depreciation Amortization | 22,554 | 18,943 | 13,598 | 12,064 | 7,819 |
| Accounts receivable | 10,479 | -6,778 | 1,238 | -3,782 | 1,523 |
| Accounts payable and accrued liabilities | 1,325 | -3,652 | 962 | -794 | 1,214 |
| Other Working Capital | -41,436 | -104,118 | 210,863 | 53,601 | 1,986 |
| Other Operating Activity | 4,736 | -163,508 | 8,276 | 15,084 | -19,864 |
| Operating Cash Flow | $-63,593 | $-108,441 | $212,031 | $36,094 | $-53,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 47,396 | -197,495 | -217,178 | 24,585 | -34,450 |
| PPE Investments | -13,052 | -13,414 | -13,665 | -2,293 | -1,042 |
| Net Acquisitions | 10,147 | N/A | N/A | -80,400 | N/A |
| Purchase Of Investment | -250 | -1,349 | 0 | N/A | N/A |
| Sale Of Investment | N/A | 2,848 | 0 | 5,181 | 4,397 |
| Purchase Sale Intangibles | -4,319 | -2,880 | -3,402 | -2,717 | -1,514 |
| Other Investing Activity | -20,547 | -2,880 | -3,402 | -2,717 | -1,514 |
| Investing Cash Flow | $23,694 | $-212,290 | $-234,245 | $-55,644 | $-32,609 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,694 | 6,394 | 12,048 | 157,056 | N/A |
| Debt Repayment | -4,354 | -2,827 | -7,239 | -134,757 | -7,851 |
| Common Stock Issued | 4,356 | 198,156 | 102,776 | 21,351 | 86,364 |
| Other Financing Activity | 0 | 278 | 0 | 0 | 70,950 |
| Financing Cash Flow | $4,696 | $202,001 | $107,585 | $43,650 | $149,463 |
| Beginning Cash Position | 105,255 | 223,985 | 138,614 | 114,514 | 50,885 |
| End Cash Position | 70,052 | 105,255 | 223,985 | 138,614 | 114,514 |
| Net Cash Flow | $-35,203 | $-118,730 | $85,371 | $24,100 | $63,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,593 | -108,441 | 212,031 | 36,094 | -53,225 |
| Capital Expenditure | -13,237 | -13,414 | -13,665 | -2,293 | -1,042 |
| Free Cash Flow | -76,830 | -121,855 | 198,366 | 33,801 | -54,267 |